Humoral and Cellular Immune Response to RNA Immunization with Flavivirus Replicons Derived from Tick-Borne Encephalitis Virus
Open Access
- 15 December 2005
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 79 (24), 15107-15113
- https://doi.org/10.1128/jvi.79.24.15107-15113.2005
Abstract
A new vaccination principle against flaviviruses, based on a tick-borne encephalitis virus (TBEV) self-replicating noninfectious RNA vaccine that produces subviral particles, has recently been introduced (R. M. Kofler, J. H. Aberle, S. W. Aberle, S. L. Allison, F. X. Heinz, and C. W. Mandl, Proc. Natl. Acad. Sci. USA7:1951-1956, 2004). In this study, we evaluated the potential of the self-replicating RNA vaccine in mice in comparison to those of live, attenuated vaccines and a formalin-inactivated whole-virus vaccine (ImmunInject). For this purpose, mice were immunized using gene gun-mediated application of the RNA vaccine and tested for CD8+T-cell responses, long-term duration, neutralizing capacity, and isotype profile of specific antibodies and protection against lethal virus challenge. We demonstrate that the self-replicating RNA vaccine induced a broad-based, humoral and cellular (Th1 and CD8+T-cell response) immune response comparable to that induced by live vaccines and that it protected mice from challenge. Even a single immunization with 1 μg of the replicon induced a long-lasting antibody response, characterized by high neutralizing antibody titers, which were sustained for at least 1 year. Nevertheless, it was possible to boost this response further by a second injection with the RNA vaccine, even in the presence of a concomitant CD8+T-cell response. In this way it was possible to induce a balanced humoral and cellular immune response, similar to infection-induced immunity but without the safety hazards of infectious agents. The results also demonstrate the value of TBEV replicon RNA for inducing protective long-lasting antiviral responses.Keywords
This publication has 43 references indexed in Scilit:
- Tumor-Infiltrating Dendritic Cell Subsets of Progressive or Regressive Tumors Induce Suppressive or Protective Immune ResponsesCancer Research, 2005
- Flavivirus Immunization with Capsid-Deletion Mutants: Basics, Benefits, and BarriersViral Immunology, 2004
- T helper responses to Japanese encephalitis virus infection are dependent on the route of inoculation and the strain of mouse usedJournal of General Virology, 2003
- Generation of CTL responses using Kunjin replicon RNAImmunology & Cell Biology, 2003
- Capsid Protein C of Tick-Borne Encephalitis Virus Tolerates Large Internal Deletions and Is a Favorable Target for Attenuation of VirulenceJournal of Virology, 2002
- Molecular Organization of a Recombinant Subviral Particle from Tick-Borne Encephalitis VirusMolecular Cell, 2001
- Immunization with plasmid DNA encoding the envelope glycoprotein of Japanese Encephalitis virus confers significant protection against intracerebral viral challenge without inducing detectable antiviral antibodiesVaccine, 1999
- DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boostVaccine, 1996
- Protection of adult but not newborn mice against lethal intracerebral challenge with Japanese encephalitis virus by adoptively transferred virus-specific cytotoxic T lymphocytes: requirement for L3T4+ T cellsJournal of General Virology, 1996
- Recombinant and virion-derived soluble and particulate immunogens for vaccination against tick-borne encephalitisVaccine, 1995